NO306048B1 - Anvendelse av unilamellaer liposomformulering omfattende et prostagladin - Google Patents

Anvendelse av unilamellaer liposomformulering omfattende et prostagladin

Info

Publication number: NO306048B1
Authority: NO; Norway
Prior art keywords: prostagladin; prostaglandin; liposome formulation; cell activation; adhesion
Prior art date: 1991-05-07

Application number

NO934016A

Other languages

English (en)

Norwegian (no)

Other versions

NO934016L (no

NO934016D0 (no

Inventor

Marc J Ostro

Original Assignee

Liposome Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-07

Filing date

1993-11-05

Publication date

1999-09-13

1993-11-05 Application filed by Liposome Co Inc filed Critical Liposome Co Inc

1993-11-05 Publication of NO934016L publication Critical patent/NO934016L/no

1993-11-05 Publication of NO934016D0 publication Critical patent/NO934016D0/no

1999-09-13 Publication of NO306048B1 publication Critical patent/NO306048B1/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Dispersion Chemistry (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO934016A 1991-05-07 1993-11-05 Anvendelse av unilamellaer liposomformulering omfattende et prostagladin NO306048B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US69731491A	1991-05-07	1991-05-07
US87620092A	1992-04-30	1992-04-30
PCT/US1992/003895 WO1992019243A1 (en)	1991-05-07	1992-05-07	Liposomal prostaglandin formulations

Publications (3)

Publication Number	Publication Date
NO934016L NO934016L (no)	1993-11-05
NO934016D0 NO934016D0 (no)	1993-11-05
NO306048B1 true NO306048B1 (no)	1999-09-13

Family

ID=27105991

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO934016A NO306048B1 (no)	1991-05-07	1993-11-05	Anvendelse av unilamellaer liposomformulering omfattende et prostagladin

Country Status (15)

Country	Link
EP (1)	EP0512916B1 (de)
JP (1)	JPH06507417A (de)
KR (1)	KR100300772B1 (de)
AT (1)	ATE176401T1 (de)
AU (1)	AU664704B2 (de)
CA (1)	CA2108788C (de)
DE (1)	DE69228332T2 (de)
DK (1)	DK0512916T3 (de)
ES (1)	ES2128343T3 (de)
FI (1)	FI934913A7 (de)
GR (1)	GR3029641T3 (de)
IE (1)	IE921461A1 (de)
MX (1)	MX9202131A (de)
NO (1)	NO306048B1 (de)
WO (1)	WO1992019243A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5811118A (en) *	1987-05-22	1998-09-22	The Liposome Company, Inc.	Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
US5925375A (en) *	1987-05-22	1999-07-20	The Liposome Company, Inc.	Therapeutic use of multilamellar liposomal prostaglandin formulations
US5882678A (en) *	1990-01-12	1999-03-16	The Liposome Co, Inc.	Interdigitation-fusion liposomes containing arachidonic acid metabolites
US5610148A (en) *	1991-01-18	1997-03-11	University College London	Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) *	1991-01-18	1997-05-13	University College London	Depot formulations
CZ286632B6 (cs)	1992-09-29	2000-05-17	Inhale Therapeutic Systems	Farmaceutický prostředek
US5853755A (en) *	1993-07-28	1998-12-29	Pharmaderm Laboratories Ltd.	Biphasic multilamellar lipid vesicles
WO1995012389A1 (en) *	1993-11-04	1995-05-11	The Liposome Company, Inc.	Multilamellar liposomal arachidonic acid metabolite formulations
ES2126868T3 (es) *	1993-11-16	1999-04-01	Liposome Co Inc	Liposomas de fusion por interdigitacion que contienen metabolitos de acido araquidonico.
EP0738151A1 (de) *	1994-01-11	1996-10-23	The Liposome Company, Inc.	Behandlung unter berwendung von arachidonsaeurmetaboliten und teilchenfoermige zubereitungen
EP1462096B1 (de)	1994-03-07	2008-12-10	Nektar Therapeutics	Verfahren und Zusammensetzung für die pulmonale Darreichung von Insulin
US5718917A (en) *	1995-12-15	1998-02-17	Harvard Scientific Corporation	PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
US6001333A (en) *	1997-09-12	1999-12-14	See; Jackie R.	Methods of preparing micro encapsulated agents for use in the detection of tumors by CT imaging
US20060165606A1 (en)	1997-09-29	2006-07-27	Nektar Therapeutics	Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en)	1997-09-29	2003-05-20	Inhale Therapeutic Systems, Inc.	Methods of spray drying pharmaceutical compositions
US6309623B1 (en)	1997-09-29	2001-10-30	Inhale Therapeutic Systems, Inc.	Stabilized preparations for use in metered dose inhalers
US7871598B1 (en)	2000-05-10	2011-01-18	Novartis Ag	Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
WO2003053411A1 (en)	2001-12-19	2003-07-03	Nektar Therapeutics	Pulmonary delivery of aminoglycosides
WO2008018932A2 (en) *	2006-05-01	2008-02-14	The Board Of Trustees Of The Leland Stanford Junior University	Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury
CA3070951C (en) *	2017-07-24	2023-03-21	Pharmosa Biopharm Inc.	Liposome compositions comprising weak acid drugs and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS58222014A (ja) *	1982-06-18	1983-12-23	Taisho Pharmaceut Co Ltd	プロスタグランジンｅ↓１脂肪乳剤
EP0153858A3 (de) *	1984-02-29	1985-12-11	The Upjohn Company	Therapeutische Anwendung von Protaglandinen
US4820732A (en) *	1985-10-04	1989-04-11	The Upjohn Company	Method and compositions for reducing dysfunction in angioplasty procedures
KR970005171B1 (ko) *	1987-05-22	1997-04-14	더 리포조옴 캄파니, 인코포레이티드	아라키돈산 대사물질 관련 리포좀 제조방법 및 그 제제

1992
- 1992-05-06 AT AT92401262T patent/ATE176401T1/de not_active IP Right Cessation
- 1992-05-06 DE DE69228332T patent/DE69228332T2/de not_active Expired - Fee Related
- 1992-05-06 EP EP92401262A patent/EP0512916B1/de not_active Expired - Lifetime
- 1992-05-06 DK DK92401262T patent/DK0512916T3/da active
- 1992-05-06 ES ES92401262T patent/ES2128343T3/es not_active Expired - Lifetime
- 1992-05-07 FI FI934913A patent/FI934913A7/fi not_active Application Discontinuation
- 1992-05-07 MX MX9202131A patent/MX9202131A/es not_active IP Right Cessation
- 1992-05-07 CA CA002108788A patent/CA2108788C/en not_active Expired - Fee Related
- 1992-05-07 KR KR1019930703258A patent/KR100300772B1/ko not_active Expired - Fee Related
- 1992-05-07 JP JP4512039A patent/JPH06507417A/ja active Pending
- 1992-05-07 WO PCT/US1992/003895 patent/WO1992019243A1/en not_active Ceased
- 1992-05-07 AU AU20273/92A patent/AU664704B2/en not_active Ceased
- 1992-07-01 IE IE146192A patent/IE921461A1/en not_active IP Right Cessation
1993
- 1993-11-05 NO NO934016A patent/NO306048B1/no unknown
1999
- 1999-03-09 GR GR990400732T patent/GR3029641T3/el unknown

Also Published As

Publication number	Publication date
MX9202131A (es)	1993-04-01
FI934913A0 (fi)	1993-11-05
CA2108788C (en)	2003-09-30
NO934016L (no)	1993-11-05
GR3029641T3 (en)	1999-06-30
WO1992019243A1 (en)	1992-11-12
JPH06507417A (ja)	1994-08-25
EP0512916A3 (en)	1992-12-09
AU664704B2 (en)	1995-11-30
FI934913L (fi)	1993-11-05
AU2027392A (en)	1992-12-21
EP0512916A2 (de)	1992-11-11
DE69228332T2 (de)	1999-09-16
CA2108788A1 (en)	1992-11-12
DE69228332D1 (de)	1999-03-18
NO934016D0 (no)	1993-11-05
IE921461A1 (en)	1992-11-18
DK0512916T3 (da)	1999-09-20
FI934913A7 (fi)	1993-11-05
ATE176401T1 (de)	1999-02-15
ES2128343T3 (es)	1999-05-16
EP0512916B1 (de)	1999-02-03
KR100300772B1 (ko)	2001-10-22

Similar Documents

Publication	Publication Date	Title
NO306048B1 (no)	1999-09-13	Anvendelse av unilamellaer liposomformulering omfattende et prostagladin
FI891389A0 (fi)	1989-03-23	Menetelmä makeutusaineen valmistamiseksi
DE58906076D1 (de)	1993-12-09	Benzophenonderivate und deren Herstellung.
FI890282A0 (fi)	1989-01-19	Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI95381C (fi)	1996-01-25	Menetelmä terapeuttisesti käyttökelpoisten, raseemisten tai optisesti aktiivisten pyrido/1,2-a/pyratsiinien valmistamiseksi
JPS6436607A (en)	1989-02-07	Manufacture of polyolefin with broad molecular weight distribution
DE3876969D1 (de)	1993-02-04	7-(1-azetidinyl)-1,4-dihydro-4-oxochinolin-3-carbonsaeure-derivate, ihre herstellung und ihre verwendung als arzneimittel.
DE3675467D1 (de)	1990-12-13	Herstellung von verringerte verfaerbung und anbrennung aufzeigende, flammwidrige polyurethanweichschaeumen.
FI880815A0 (fi)	1988-02-22	Menetelmä uusien terapeuttisesti käyttökelpoisten 5-okso-4,5-dihydro-imidatso/1,5-a/kinatsoliinijohdannaisten valmistamiseksi
FI912950A0 (fi)	1991-06-18	Belaeggningskomposition.
DE3577722D1 (de)	1990-06-21	Derivat des adult-t-zell-leukemiavirus-antigenpeptids.
FI892908L (fi)	1989-12-15	Menetelmä uusien terapeuttisesti käyttökelpoisten imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
FI892684A0 (fi)	1989-06-01	Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
FI92202B (fi)	1994-06-30	Menetelmä uusien terapeuttisesti käyttökelpoisten 4-substituoitujen pyratsolo/3,4-d/pyrimidiinijohdannaisten valmistamiseksi
FI102066B1 (fi)	1998-10-15	Menetelmä farmakologisesti aktiivisen 2,5,6,7-tetranor-4,8-inter-m-fenyleeni-PGI2-johdannaisen valmistamiseksi sekä välituote
FI873750A0 (fi)	1987-08-28	Anordning foer detektering av en begynnande uppvisningsansats i ett ark under framstaellning av arket.
FI890478A7 (fi)	1989-08-04	Menetelmä uusien terapeuttisesti käyttökelpoisten 4-okso-4H-pyrido/1,2-a/pyrimidiini-3-karboksamidijohdannaisten valmistamiseksi
FI931891A0 (fi)	1993-04-27	Menetelmä uusien terapeuttisesti käyttökelpoisten 7,8-dihydroksi-1H-imidatso- ja pyratsolo/3,4-f/kinoksaliinijohdannaisten valmistamiseksi
FI96855B (fi)	1996-05-31	Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi
FI912247A0 (fi)	1991-05-09	Menetelmä terapeuttisesti käyttökelpoisten pyrrolo/2,3-b/indoliketonijohdannaisten valmistamiseksi
DE3875807D1 (de)	1992-12-17	3-acylaminomethyl-5,6,7,8-tetrahydroimidazo(1,2-a)pyridinderivate, ihre herstellung und therapeutische verwendung.
FI921091A0 (fi)	1992-03-13	Menetelmä terapeuttisesti aktiivisen 2-fenyylisubstituoidun imidatso[1,5-a]kinoksaliini-1,3(2H,5H)-dionijohdannaisen valmistamiseksi
FI882299L (fi)	1989-03-22	Saett och anordning foer mammografisk stereotaktisk punktion av patologiska foeraendringar i dett kvinnliga broestet.
DE69124245D1 (de)	1997-02-27	Herstellung von Bolzen
GR880100196A (el)	1989-01-31	Υποκατεστημενα 1,3-διοξολαν-και 1,3-διοξαν-παραγωγα,μεθοδοι για την παρασκευη τους και η χρηση τους